Sanofi-Aventis

Our company’s motto is straightforward: “Because health matters.”

In the U.S., sanofi-aventis is committed to maintaining the innovative approach to pharmaceuticals established by our parent company, headquartered in Paris, France. Our company is making daily advances in the complex realms of oncology, the central nervous system, cardiovascular/thrombosis, diabetes and internal medicine, among other therapeutic areas.

Our nearly 12,000 researchers worldwide have developed an extraordinary and ever increasing range of compounds, including several that have placed us on the front lines in the battle against cancer.

In addition, our oncology pipeline includes novel therapies that could help many thousands of cancer patients in the future. We intend to nurture that pipeline to ensure that we continue to fight the good fight against this disease until it is won.

But at sanofi-aventis, we believe our responsibility to health goes beyond the marketplace. In the realm of oncology, the patient challenge is multifaceted, including the need for emotional, family and social support as well as educational and other resources.

That is why, along with our various philanthropic efforts and educational grants in the field of oncology, we partner with groups such as the National Breast Cancer Coalition (NBCC), Y-Me and the National Coalition for Cancer Survivorship (NCCS). These partnerships allow us to hear patient voices, broaden our knowledge of those in need and multiply the benefits we can provide.

Being on the front lines in the fight against disease has a special meaning for sanofi-aventis employees. We have the privilege of knowing that what we do each day in all of our therapeutic categories touches hundreds of thousands of patients each year,.

We take tremendous pride in being a source of hope and a force for discovery. . . and to have helped lead the way back for so many.

Sanofi-aventis...Because health matters.

US. DOC. 07.90.061